Idexx Laboratories
IDXX
1,055 hedge funds and large institutions have $36.5B invested in Idexx Laboratories in 2023 Q1 according to their latest regulatory filings, with 138 funds opening new positions, 344 increasing their positions, 404 reducing their positions, and 71 closing their positions.
94% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 71
29% more funds holding in top 10
Funds holding in top 10: 24 → 31 (+7)
19% more capital invested
Capital invested by funds: $30.6B → $36.5B (+$5.85B)
6% more funds holding
Funds holding: 1,000 → 1,055 (+55)
0.92% less ownership
Funds ownership: 88.92% → 87.99% (-0.92%)
12% less call options, than puts
Call options by funds: $187M | Put options by funds: $213M
15% less repeat investments, than reductions
Existing positions increased: 344 | Existing positions reduced: 404
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$150M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$143M |
| 3 |
Millennium Management
New York
|
+$124M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$112M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$96.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$456M |
| 2 |
Fundsmith LLP
London,
United Kingdom
|
-$234M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$227M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$190M |
| 5 |
Select Equity Group
New York
|
-$157M |
IDXX Hedge Fund Activity: Q1 2023 in Review
1,055 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2023, worth a combined $36.5B — up 19% from $30.6B a quarter earlier.
Buyers outnumbered sellers: 138 funds opened new IDXX positions and 71 closed out — a net gain of 67 holders — while 344 added to existing stakes and 404 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $150M. The largest seller was Fidelity Investments, cutting an estimated $456M.
- 1,055 institutional investors held Idexx Laboratories (IDXX) as of Q1 2023, up from 1,000 in Q4 2022.
- Funds reported $36.5B of Idexx Laboratories stock for Q1 2023, up 19% quarter-over-quarter.
- 138 funds opened new Idexx Laboratories positions in Q1 2023 and 71 closed out, a net change of +67 holders.
- The largest Idexx Laboratories buyer in Q1 2023 was Citadel Advisors, an estimated $150M added.
- The largest Idexx Laboratories seller in Q1 2023 was Fidelity Investments, an estimated $456M sold.
Based on aggregated 13F filings for Q1 2023.